Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.48 USD | -0.14% | +8.21% | +54.37% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Business Summary
Number of employees: 999
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biosimilar Medicines
100.0
%
| 83 | 100.0 % | 91 | 100.0 % | +10.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
69.5
%
| 39 | 47.5 % | 64 | 69.5 % | +61.06% |
North America
20.0
%
| 31 | 37.1 % | 18 | 20.0 % | -40.53% |
Asia and Other
10.5
%
| 0 | 0.0 % | 10 | 10.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 01/11/18 |
Joel Morales
DFI | Director of Finance/CFO | 46 | 31/01/20 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/22 |
Chief Tech/Sci/R&D Officer | 50 | 30/09/19 | |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 31/05/20 |
Investor Relations Contact | - | 01/03/22 | |
Ming Li
PRN | Corporate Officer/Principal | 47 | - |
Anil Okay
PRN | Corporate Officer/Principal | 38 | - |
Helga Zharov
LAW | General Counsel | 57 | 30/04/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Linda McGoldrick
BRD | Director/Board Member | 68 | 15/06/22 |
Helga Zharov
LAW | General Counsel | 57 | 30/04/20 |
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 01/11/18 |
Tomas Ekman
BRD | Director/Board Member | 56 | 31/12/18 |
Richard Davies
BRD | Director/Board Member | 62 | 31/12/18 |
Árni Harðarson
BRD | Director/Board Member | 57 | 15/06/22 |
Lisa Graver
BRD | Director/Board Member | 53 | 15/06/22 |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 31/05/20 |
Ann Merchant
BRD | Director/Board Member | 59 | 15/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 266,821,844 | 72,673,643 ( 27.24 %) | 0 | 27.24 % |
Company contact information
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Company Alvotech